Oxford Immunotec Global PLC Ordinary Shares
OXFD
OXFD was delisted on the 5th of March, 2021.
77 hedge funds and large institutions have $337M invested in Oxford Immunotec Global PLC Ordinary Shares in 2017 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 32 increasing their positions, 26 reducing their positions, and 12 closing their positions.
23% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 26
3% less funds holding
Funds holding: 79 → 77 (-2)
13% less capital invested
Capital invested by funds: $385M → $337M (-$48.3M)
17% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 12
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Consonance Capital Management
New York
|
+$16.4M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
+$7.42M |
| 3 |
DM
Deerfield Management
New York
|
+$4.66M |
| 4 |
RG
Redmile Group
San Francisco,
California
|
+$3.91M |
| 5 |
Millennium Management
New York
|
+$2.13M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RI
RTW Investments
New York
|
-$9.62M |
| 2 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$4.8M |
| 3 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$2.73M |
| 4 |
CCI
Columbus Circle Investors
|
-$2.64M |
| 5 |
ECM
Endurant Capital Management
San Mateo,
California
|
-$2.36M |
OXFD Hedge Fund Activity: Q4 2017 in Review
77 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Oxford Immunotec Global PLC Ordinary Shares (OXFD) for Q4 2017, worth a combined $337M — down 13% from $385M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of OXFD and 10 opened new positions — a net loss of 2 holders — while 26 trimmed existing stakes and 32 added.
The largest buyer was Consonance Capital Management, opening a new position worth an estimated $16.4M. The largest seller was RTW Investments, cutting an estimated $9.62M.
- 77 institutional investors held Oxford Immunotec Global PLC Ordinary Shares (OXFD) as of Q4 2017, down from 79 in Q3 2017.
- Funds reported $337M of Oxford Immunotec Global PLC Ordinary Shares stock for Q4 2017, down 13% quarter-over-quarter.
- 10 funds opened new Oxford Immunotec Global PLC Ordinary Shares positions in Q4 2017 and 12 closed out, a net change of -2 holders.
- The largest Oxford Immunotec Global PLC Ordinary Shares buyer in Q4 2017 was Consonance Capital Management, an estimated $16.4M added.
- The largest Oxford Immunotec Global PLC Ordinary Shares seller in Q4 2017 was RTW Investments, an estimated $9.62M sold.
Based on aggregated 13F filings for Q4 2017.